CNE100003PR1
CNE100003PR1
BRIGHTGENE BIO-MEDICAL TECHNOLO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 14.61B EUR | 15.26B EUR | 20.51B EUR |
Enterprise Value | 16.23B EUR | 16.51B EUR | 22.2B EUR |
Valuation Multiples | |||
Trailing P/E | 145.78x | 226.57x | 668.85x |
Forward P/E | 56.83x | -- | -- |
Price to Sales | 10.71x | 11.59x | 16.92x |
Price to Book | 4.78x | 5x | 8.1x |
EV/Revenue | 11.9x | 12.54x | 18.32x |
EV/EBITDA | 60.56x | 104.93x | 299.69x |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -1.1% | -0.42% | -1.15% |